Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.
about
Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@en
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@nl
type
label
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@en
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@nl
prefLabel
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@en
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@nl
P2093
P2860
P356
P1433
P1476
Silencing IGFBP-2 decreases pa ...... chemotherapeutic sensitivity.
@en
P2093
Jisheng Hu
Shangha Pan
Yongwei Wang
P2860
P304
61674-61686
P356
10.18632/ONCOTARGET.18669
P407
P577
2017-06-27T00:00:00Z